What makes a good RP?
Recommendation

22 October 2026
Good Distribution Practice of Active Substances for Human and Veterinary Medicinal Products
In a recent blog, the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) discusses possibilities (and expectations) for an effective appointment and training for the Responsible Person (RP) named on the Wholesale Distribution Authorisation (WDA).
The MHRA sees a number of "key areas" an RP and its employer should consider and which MHRA "will address in turn":
- Knowledge of GDP and the relevant regulations - this is the text book stuff.
- Industry experience - relevant GDP experience.
- Familiarity with the GDP operations of the Licence Holder - particularly challenging in a large organisation.
- Induction/primary training - role familiarity.
- Role definition and place within the organisation - sufficient seniority and influence.
- Delegation and training others - The RP is responsible for all GDP activities, even those delegated.
- Training records - RP, Licence Holder and staff.
- Continuing development for the RP - the supply chain continually presents new challenges.
Source: Quelle: MHRA Inspectorate Blog "The Responsible Person named on the WDA -Part 2: Effective Appointment and Training".
Related GMP News
30.09.2026European GDP Association Developments May through August 2026
30.09.2026Warehouse Temperature Excursions: What Does the FDA Expect?
30.09.2026Version 4.0 of the Swissmedic Document on Notifications of Changes Published
30.09.2026USA: Court Stops Warehouse Activities Following Persistent Insanitary Warehouse Conditions
30.09.2026GDP Non-Compliance Report: CAPA Measures must not only be Promised but also Implemented
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September


